pharm exam 1 multiple choice
which of the following would be correctly categorized as objective behavior? a. a list of herbal supplements regularly used provided by the patient b. lab values associated with the drugs the patient is taking c. the ages & relationship of all household members to the patient d. usual dietary patterns & food intake
B
Respect for persons is a core ethical principle of human subjects research. Which of the following best describes this principle? a. Duty to protect research subjects from harm. b. Fair selection of research subjects. c. Right to self-determination. d. Patients are independent and capable of making decisions in their own best interests.
D
The community health nurse is teaching a group of elderly residents in an assisted care facility about medication use. The nurse will remind the residents that OTC medications a. are not as effective as prescription medications. b. are not recommended for older adults. c. are safer than prescription medications. d. should be reviewed with a provider before taking.
D
The nurse administers a centrally acting analgesic to a patient who has been receiving it for 1 day after orthopedic surgery with successful pain relief. The patient reports no change in pain 30 minutes after the medication is given. The nurse recognizes that this patient is likely exhibiting a. drug-seeking behavior. b. drug tolerance c. the placebo effect d. tachyphylaxis
D
The nurse is administering two drugs to a patient and learns that both drugs are highly protein- bound. The nurse may expect a. decreased bioavailability of both drugs. b. decreased drug effects. c. decreased drug interactions. d. increased risk of adverse effects.
D
A patient is prescribed a medication and asks the nurse if the drug is available in a generic form. The nurse understands that a generic drug name is a. a registered trademark. b. always capitalized. c. related to the drug's chemical structure. d. nonproprietary.
D
The nurse is enrolling subjects for a clinical drug trial in which subjects will be randomly assigned to either a treatment or a placebo group. The pills in both groups will be in identical packaging with identical appearance. The group that receives the intervention is the a. control group. b. experimental group. c. dependent group. d. independent group.
B
A patient is taking methadone as part of a heroin withdrawal program. The nurse understands that, in this instance, methadone is classified as which drug schedule? a. C-I b. C-II c. C-III d. C-V
B
A patient is taking phenytoin to prevent seizures. The nurse knows that phenytoin is highly protein-bound and has sedating effects. The nurse reviews the patient's chart and notes a low serum albumin. The nurse will notify the provider and observe the patient for which effects? a. Decreased sedative effects b. Increased sedative effects c. Increased seizures d. No change in effects
B
The FDA recommends genetic testing of which of the following for patients prior to initiating abacavir due to a risk of potentially fatal multiorgan hypersensitivity in 6-10% of users? a. CYP2C19 b. HLA-B*5701 c. CYP2D6 d. UGT1A1
B
The nurse is assisting with a clinical drug trial in which the side effects of two effective drugs are being compared. A patient who would benefit from either drug has elected to withdraw from the study, and the nurse assists with the paperwork to facilitate this. This is an example of a. autonomy. b. beneficence. c. justice. d. veracity.
A
The nurse is assisting with data collection in a study of drug effects in a small group of healthy subjects. The nurse assists with blood and urine collection to determine serum drug levels and the presence of metabolites in urine. Which phase of drug development does this best represent? a. Phase I b. Phase II c. Phase III d. Phase IV
A
The nurse gives a highly metabolized medication to a patient with a history of liver disease. The nurse will monitor this patient for a. decreased drug effects. b. increased drug effects. c. decreased therapeutic range. d. increased therapeutic range.
B
There are many legal and ethical issues related to pharmacogenomics. Which of the following questions is not related to privacy? a. Who has access to patient genetic information? b. All patients cannot afford pharmacogenetic testing. c. Who owns the genetic information? d. Concerns about patient "labeling" based on genetic code.
B
The nurse is caring for a patient who receives theophylline, which has a narrow therapeutic index. The patient has been receiving cimetidine but will stop taking that drug in 2 days. In 2 days, the nurse will observe the patient closely for a. decreased effectiveness of theophylline. b. increased effectiveness of theophylline. c. decreased toxicity of theophylline. d. prolonged effectiveness of theophylline.
B
Which of the following best describes pharmacogenetics? a. What the drug does to the body. b. How a patient's genomes affect their response to medications. c. What the body does to the drug. d. How drugs alter patient's genes.
B
A patient is prescribed bethanechol (a cholinergic agent) to help manage her urinary retention. Which of the following would correctly describe a cholinergic response? a. Pupillary constriction b. Increased heart rate c. Bronchiole relaxation d. Increased blood pressure
A
An adolescent patient who has acne is given a regimen of topical medications and an oral antibiotic that generally clears up lesions to fewer than 10 within 6 to 8 weeks. At a 2-month follow-up, the patient continues to have more than 25 lesions. The child's parent affirms that the child is using the medications as prescribed. Which statement below is correct for this patient to evaluate the outcome? a. "Goal of fewer than 10 lesions in 6 to 8 weeks is not met." b. "Goal that the medication will be effective is not met." c. "Goal that the patient will take medications as prescribed is not met." d. "Goal that the patient understands the medication regimen is not met."
A
During a clinical drug trial for a new medication, researchers note a previously unknown serious adverse effect occurring in more than 50% of subjects. The study is discontinued. Which ethical principle is being exercised? a. Beneficence b. Justice c. Respect for persons d. Veracity
A
Gregor Mendel is known for which of the following? a. First explaining the difference between dominant and recessive genes in inheritance b. Discovering the structure of DNA c. Mapping roughly 25,000 genes in human DNA d. Coining the term pharmacogenomics
A
The Genetic Information Nondiscrimination Act (GINA) was enacted to a. prohibit insurance companies from requiring genetic testing to obtain health insurance. b. allow for free pharmacogenomic testing for all US citizens. c. provide research funding for inclusion of diverse populations in pharmacogenomic studies. d. prohibit use of certain medications unless pharmacogenomic testing is completed.
A
The labeling for clopidogrel discusses pharmacogenomic testing for genetic variation in which of the following? a. CYP2C19 b. HLA-B*5701 c. CYP2D6 d. UGT1A1
A
The nurse administers albuterol to a patient who has asthma. The albuterol acts by stimulating beta2-adrenergic receptors to cause bronchodilation. The nurse understands that albuterol is a beta-adrenergic a. agonist. b. antagonist. c. inhibitor. d. depressant.
A
The nurse is preparing an injectable drug and wants to administer it via the route that will allow for the most rapid absorption possible. How will the nurse give this medication (if possible)? a. IM into the deltoid muscle b. IM into the gluteal muscle c. SQ into abdominal tissue d. SQ into the upper arm
A
The nurse is preparing to administer a schedule II injectable drug and is drawing up half of the contents of a single-use vial. Which nursing action is correct? a. Ask another nurse to observe and cosign wasting the remaining drug from the vial. b. Keep the remaining amount in the patient's drawer to give at the next dose. c. Record the amount unused in the patient's medication record. d. Dispose of the vial with the remaining drug into a locked collection box.
A
The nurse is preparing to administer furosemide to a patient who takes digoxin. The nurse will plan to monitor the patient for a. digoxin toxicity. b. decreased digoxin effects. c. furosemide toxicity. d. decreased furosemide effects.
A
The nurse is preparing to administer the first dose of digoxin (Lanoxin) to a patient and notes that the initial dose ordered is much higher than the ordered maintenance dose. Which of the following describes why the first dose is higher? a. Digoxin requires a loading dose. b. Digoxin undergoes first-pass metabolism when initially administered. c. Digoxin has a long duration of action. d. Digoxin has a short half-life.
A
The nurse prepares to change a patient's medication from an IV to an oral form and notes that the oral form is ordered in a higher dose. The nurse understands that this is due to differences in a. bioavailability. b. pinocytosis. c. protein binding. d. tachyphylaxis.
A
Which of the following best describes preclinical in vivo testing? a. A comparison of experimental and control data in animals. b. A study conducted in a test tube in a laboratory. c. A study that determines the effects of the experimental product in human participants. d. A study to assess the seriousness of the disease to be treated.
A
the nurse is preparing to administer a medication & reviews the patient's chart for drug allergies, serum creatinine, & blood urea nitrogen (BUN) levels. the nurse's actions are reflective of which of the following? a. recognizing cues (assessment) b. analyze cues & prioritize hypothesis (analysis) c. take action (nursing interventions) d. generate solutions (planning)
A
Which of the following are responsibilities of the FDA? (Select all that apply.) a. To ensure a drug has accurate labeling b. To ensure a drug is affordable c. To ensure a drug is effective d. To ensure a drug is free from adverse reactions e. To ensure a drug is tested for harmful effects
A C E
A patient has been taking a drug for several years and tells the nurse it is no longer working. The nurse learns that the patient has recently begun taking an over-the-counter (OTC) antacid medication. What does the nurse suspect is occurring? a. An adverse drug reaction b. A drug interaction c. Drug incompatibility d. Drug tolerance
B
A patient has been taking warfarin (Coumadin), which is highly protein-bound. The patient will begin taking gemfibrozil, which is also highly protein-bound. The nurse will observe the patient closely for a. decreased effects of warfarin. b. increased effects of warfarin. c. decreased effects of gemfibrozil. d. decreased effects of both drugs.
B
A patient is diagnosed with Stevens-Johnson syndrome and the provider thinks this is related to an HLA B*1502 variant that resulted in drug toxicity. The nurse would know that which of the following medications is likely to blame? a. Warfarin b. Carbamazepine c. Codeined. d. Irinotecan
B
A patient who takes a drug that undergoes gastric absorption will begin taking an opioid analgesic after sustaining an injury in a motor vehicle accident. The nurse will observe the patient closely for which effects? a. Decreased effects of the first drug b. Increased effects of the first drug c. Decreased effects of the narcotic d. Increased effects of the narcotic
B
If a drug has a half-life of 12 hours and is given twice daily starting at 0800 on a Monday, when will a steady state be achieved? a. 0800 on Tuesday b. 0800 on Wednesday c. 0800 on Thursday d. 0800 on Friday
B
In a 5-year clinical trial investigating a new cancer treatment, researchers note overwhelming improvement in almost all of the subjects in the treatment group during the second year of the trial. It is decided to stop the trial early and report the findings due to the overwhelmingly beneficial effects. This decision was made based on which ethical principle? a. Beneficence b. Justice c. Respect for persons d. Veracity
B
The nurse is obtaining consent from a subject newly recruited for a clinical drug trial that will last for 6 months. All subjects will be given gift certificates for participating. One subject says, "Well, I guess if the drug doesn't work, I'll just have to put up with the symptoms for 6 months." What will the nurse tell the subject? a. "Participation for the duration of the study is required." b. "Participation may end at any time without penalty." c. "Withdrawal from the study may end at any time, but the gift certificate will not be given." d. "You can request placement in the treatment group."
B
The nurse is preparing to administer a combination drug containing acetaminophen and codeine. The nurse knows that this drug is classified as which drug schedule? a. C-II b. C-III c. C-IV d. C-V
B
The nurse is preparing to administer a drug that is ordered to be given twice daily. The nurse reviews the medication information and learns that the drug has a half-life of 24 hours. What will the nurse do next? a. Administer the medication as ordered. b. Contact the provider to discuss daily dosing. c. Discuss every-other-day dosing with the provider. d. Hold the medication.
B
The nurse is preparing to administer an oral medication that is water soluble. The nurse understands that this drug a. must be taken on an empty stomach. b. requires active transport for absorption. c. should be taken with fatty foods. d. will readily diffuse into the GI tract.
B
The nurse is preparing to administer two IV medications that should not be given using the same IV tubing. The nurse understands that this is because of drug a. adverse reactions. b. incompatibility. c. interactions. d. potentiation.
B
The nurse is reviewing medication information with a nursing student prior to administering an oral drug and notes that the drug has extensive first-pass effects. Which statement by the student indicates an understanding of the first-pass effect? a. "The first-pass effect means the drug has 100% bioavailability." b. "The first-pass effect means the drug is absorbed from the GI tract into the portal vein where it is transported to the liver and metabolized." c. "The first-pass effect means the drug was given by injection and immediately metabolized." d. "The first-pass effect means the drug may be unchanged as it passes through the liver."
B
The nurse is teaching a patient about taking a once-daily medication that has a side effect of drowsiness. The nurse learns that the patient works a 7:00 PM to 7:00 AM shift in a hospital. The nurse will recommend that the patient take this medication at which time of day? a. 0600 b. 0800 c. 1800 d. 2000
B
The nurse is teaching a patient who will begin taking ciprofloxacin (Cipro). What instruction will the nurse include when teaching this patient about this drug? a. "Do not take this medication with oral contraceptive pills." b. "Take at least 1 hour after or 2 hours before taking antacids." c. "Take in the morning with your multivitamin tablet." d. "Take with milk to reduce gastric upset."
B
The nurse understands that the length of time needed for a drug to reach the minimum effective concentration (MEC) is the a. duration of action. b. onset of action. c. peak. d. time response curve.
B
The provider has ordered amoxicillin with clavulanate (Augmentin) for a child who has otitis media. The child's parent asks why this drug is necessary when amoxicillin is less expensive. The nurse will explain that clavulanate is added to amoxicillin because it a. binds with albumin to increase the amount of available amoxicillin. b. enhances the antibacterial effect of amoxicillin by inhibiting bacterial enzymes. c. inhibits hepatic blood flow, leading to increased serum drug levels of amoxicillin. d. inhibits the excretion of amoxicillin by interfering with renal function.
B
Which patients are at particularly high risk for drug interactions? (Select all that apply.) a. Patients who are acutely ill b. Patients who are taking multiple medications c. Patients who see several specialists d. Patients who take supplements and OTC medications e. Patients who use one pharmacy for several medications
B C D
A clinical drug trial focused on determining the pharmacokinetics and safety of a drug in healthy individuals is concluding. The nurse will assist with enrollment of participants into the next phase of the study which will likely include which of the following subjects? a. Healthy subjects b. Healthy and subjects with the disease the drug is being studied to treat c. Subjects with the disease the drug is being studied to treat d. Subjects with other diseases
C
A high-school student regularly forgets to use a twice-daily inhaled corticosteroid to prevent asthma flares and is repeatedly admitted to the hospital. The child's parent tells the nurse that the child has been told that forgetting to take the medication causes frequent hospitalizations. The nurse will a. encourage the child to take responsibility for taking the medication. b. reinforce the need to take prescribed medications to avoid hospitalizations. c. suggest putting the inhaler with the child's toothbrush to use before brushing teeth. d. suggest that the child's parents administer the medication to increase compliance.
C
A patient calls the clinic and tells the nurse that a newly prescribed medication isn't working. What is the nurse's next action? a. Notify the provider and discuss increasing the dose. b. Question the patient about compliance with the regimen. c. Review the drug information with the patient. d. Suggest the patient discuss changing medications with the provider.
C
A patient has been taking a drug that is 75% protein bound. The provider adds a new medication that is 90% protein bound. The nurse will expect a potential a. decreased drug effects of the first drug. b. decreased therapeutic range of the first drug. c. increased drug effects of the first drug. d. increased therapeutic range of the first drug.
C
A patient receives a prescription on which the provider has noted that a generic medication may be given. The patient asks the nurse what this means. What will the nurse tell the patient about generic drugs? a. They contain the same inert ingredients as brand-name drugs. b. They have chemical structures that are different from proprietary drugs. c. They tend to be less expensive than brand-name drugs. d. They undergo extensive testing before they are marketed.
C
A patient who is newly diagnosed with type 1 diabetes mellitus asks why insulin must be given by subcutaneous injection instead of by mouth. The nurse will explain that this is because a. absorption is diminished by the first-pass effects in the liver. b. absorption is faster when insulin is given subcutaneously. c. digestive enzymes in the GI tract break down the drug and prevent absorption. d. the oral form is less predictable with more adverse effects.
C
The nurse is preparing to administer an oral medication and wants to ensure a rapid drug action. Which form of the medication will the nurse prefer to administer? a. Capsule b. Enteric-coated pill c. Liquid suspension d. Tablet
C
A school-age child will begin taking a medication to be administered at 5 mL three times daily. The child's parent tells the nurse that, with a previous use of the drug, the child repeatedly forgot to bring the medication home from school, resulting in missed evening doses. What will the nurse recommend? a. Encourage the child to be more responsible and that it is important to take the medication as prescribed. b. Putting a note on the child's locker to encourage the child to take responsibility for medication administration. c. Asking the provider if 7.5 mL may be taken in the morning and 7.5 mL may be taken in the evening so that the correct amount is given daily. d. Taking the noon dose to school every day and giving it to the school nurse to administer.
C
An older patient must learn to administer a medication using a device that requires manual dexterity. The patient becomes frustrated and expresses lack of self-confidence in performing this task. Which action will the nurse perform next? a. Ask the patient to keep trying until the skill is learned. b. Provide written instructions with illustrations showing each step of the skill. c. Schedule multiple sessions and practice each step separately. d. Teach the procedure to family members who can administer the medication for the patient.
C
Codeine and tramadol are prodrugs that require metabolism by which enzyme prior to providing analgesic relief? a. CYP2C19 b. CYP3A4 c. CYP2D6 d. CYP1A1
C
Drugs approved to the market in the 1980s may not be proven effective in a large portion of the population. The nurse understands that this is because these drugs a. did not pass through the appropriate phases of clinical trials. b. did not require human subject protections and are invalid. c. were not always tested in women, minorities, or children. d. were tested on healthy subjects only.
C
The nurse assesses a patient who is receiving morphine sulfate intravenously using a patient- controlled analgesia pump. The nurse notes somnolence and respiratory depression, which are signs of morphine toxicity. The nurse will prepare to administer naloxone (Narcan) because it a. has synergistic effects with morphine. b. is an opioid agonist. c. is an opioid antagonist. d. potentiates the effects of morphine.
C
The nurse gives 800 mg of a drug that has a half-life of 8 hours. How much drug will be left in the body in 24 hours if no additional drug is given? a. None b. 50 mg c. 100 mg d. 200 mg
C
The nurse is caring for a patient who has ingested a large dose of aspirin several hours prior. It is determined that the patient has overdosed on aspirin. The provider orders sodium bicarbonate to be given. The nurse understands that this drug is given for which purpose? a. To counter the toxic effects of the aspirin b. To decrease the half-life of the aspirin c. To increase the excretion of the aspirin d. To neutralize the acid of the aspirin
C
The nurse is obtaining signatures on consent forms for participation in a clinical drug trial. One patient says, "I'm not sure I want to do this, but I need the cash." The nurse will take which action? a. Ask the patient to clarify concerns. b. Reinforce that cash is given to all subjects equally. c. Report this statement to the lead investigator. d. Review the elements of the study and obtain consent.
C
The nurse is preparing to give a medication to a child. The medication is approved for use in children. The child's parent asks whether the drug is safe for children. How will the nurse respond to the parent? a. "Drugs approved for use in children are tested on adults and safe doses for children are based on weights compared to adult weights." b. "Drugs approved for use in children are deemed safe for children over time when repeated use proves effectiveness and safety." c. "Drugs approved for use in children are tested for both efficacy and safety in children in order to be marketed for pediatric use." d. "Drugs approved for use in children are tested on children in post-marketing studies and on a limited basis."
C
The nurse is preparing to teach a patient who will begin taking a non-selective monoamine oxidase (MAO) inhibitor. What is most important when teaching patients about non-selective MAO inhibitors? a. Emphasizing the importance of potassium intake b. Giving detailed drug information c. Reviewing dietary guidelines d. Providing a schedule for medication administration
C
The nurse is teaching a patient who will be discharged home with a prescription for an enteric- coated tablet. Which statement by the patient indicates understanding of the teaching? a. "I may crush the tablet and put it in applesauce to improve absorption." b. "I should consume acidic foods to enhance absorption of this medication." c. "I should expect a delay in onset of the drug's effects after taking the tablet." d. "I should take this medication with high-fat foods to improve action."
C
Which drug will go through a disintegration process after it is administered? a. Intramuscular (IM) cephalosporins b. Intravenous (IV) vasopressors c. Oral analgesics d. Subcutaneous insulin
C
Which law(s) govern drug administration by nurses? a. Drug Regulation and Reform Act. b. FDA Amendments Act. c. Nurse Practice Acts. d. The Controlled Substances Act.
C
Which of the following would not be considered an important element of health teaching in drug therapy? a. Assess the patients' health literacy skills. b. Assess all of the drugs on the patients' profile for possible drug interactions. c. Avoid discussing potential side effects and adverse reactions with the patient to avoid nonadherence. d. Determine if the patient needs laboratory monitoring.
C
the nurse is using data collected to define a set of interventions to achieve the most desirable outcomes. which of the following steps is then nurse applying? a. recognizing cues (assessment) b. analyze cues & prioritize hypothesis (analysis) c. generate solutions (planning) d. take action (nursing interventions)
C
the nurse review's a patient's database and learns that the patient lives alone, is forgetful, and does not have an established routine. the patient will be sent home with three new medications to be taken at different times of the day. the nurse develops a daily medication chart and enlists a family member to put the patient's pills in a pill organizer. this is an example of which element of the nursing process? a. recognizing cues (assessment) b. analyze cues & prioritize hypothesis (analysis) c. take action (nursing interventions) d. generate solutions (planning)
C
36. A patient asks the nurse about using OTC medications. The nurse will tell the patient that OTC medications a. are not as effective as prescription medications. b. are not as safe as prescription medications. c. have fewer side effects and drug interactions than prescription medications. d. should be included when listing any medications taken by the patient.
D
A patient who is hospitalized for chronic obstructive pulmonary disease (COPD) wants to go home. The nurse and the patient discuss the patient's situation and decide that the patient may go home when able to perform self-care without dyspnea and hypoxia. This is an example of which phase of the nursing process? a. Recognizing cues (assessment) b. Analyze cues & prioritize hypothesis (analysis) c. Take action (nursing interventions) d. Generate solutions (planning)
D
A patient who takes the anticoagulant warfarin will begin taking the anticonvulsant drug carbamazepine. The nurse reviews the drug information for these drugs and learns that carbamazepine is a hepatic enzyme inducer. The nurse anticipates that which of the following may be required? a. Decrease the dose of carbamazepine. b. Increase the dose of carbamazepine. c. Decrease the dose of warfarin. d. Increase the dose of warfarin.
D
A patient will be sent home with a metered-dose inhaler, and the nurse is providing teaching. Which is a correctly written expected outcome for this process? a. The nurse will demonstrate the correct use of a metered-dose inhaler to the patient. b. The nurse will teach the patient how to administer medication with a metered-dose inhaler. c. The patient will know how to self-administer the medication using the metered- dose inhaler. d. The patient will independently administer the medication using the metered-dose inhaler at the end of the session.
D
A patient will receive penicillin to treat an infection. The provider orders probenecid (Probalan), a medication to treat gout, even though the patient does not have gout. Which action by the nurse is correct? a. Administer the drug since the provider ordered it. b. Recognize that it is being given prophylactically. c. Refuse to administer the medication since it is not indicated. d. Verify that it is being given for its secondary action.
D
Before marketing a new drug that has been approved for use based on clinical effectiveness and safety, the manufacturer wishes to study the potential new uses for the drug. This is an example of which phase of study? a. Phase I b. Phase II c. Phase III d. Phase IV
D
The nurse is developing a teaching plan for an elderly patient who will begin taking an antihypertensive drug that causes dizziness and orthostatic hypotension. Which hypothesis (problem) documented by the nurse is appropriate for this patient? a. Deficient knowledge related to drug side effects. b. Ineffective health maintenance related to age. c. Readiness for enhanced knowledge related to medication side effects. d. Risk for injury related to side effects of the medication.
D
The nurse is enrolling subjects for a double-blind experimental study. One patient asks the nurse to explain the role of the experimental group. The nurse will explain that subjects in the experimental group in this type of study a. are selected for participation in that group. b. have unique baseline characteristics. c. receive a placebo. d. receive the experimental treatment being evaluated.
D
The nurse is generating solutions (planning) for a patient who has chronic lung disease and hypoxia. The patient has been admitted for increased oxygen needs above a baseline of 2 L/min. The nurse generates an expected outcomes stating, "The patient will have oxygen saturations of >95% on room air at the time of discharge from the hospital." What is wrong with this goal? a. It cannot be evaluated. b. It is not measurable. c. It is not patient-centered. d. It is not realistic.
D
The nurse is preparing to administer a drug and learns that it is 90% protein bound. The patient's serum albumin level is low. The nurse will observe the patient for a. decreased drug absorption. b. decreased drug interactions. c. decreased drug toxicity. d. increased drug effects.
D
The nurse is preparing to administer a drug that is eliminated through the kidneys. The nurse reviews the patient's chart and notes that the patient has increased serum creatinine and blood urea nitrogen (BUN) and a low estimated glomerular filtration rate (eGFR). The nurse will perform which action? a. Administer the drug as ordered. b. Anticipate a shorter than usual half-life of the drug. c. Expect decreased drug effects when the drug is given. d. Verify that the dose ordered is appropriate based on the patient's kidney function.
D
The nurse is teaching a patient about a drug that causes photosensitivity. Which statement by the patient indicates a need for further teaching? a. "I should apply sunscreen with a sun protection factor greater than 15." b. "I should avoid sunlight when possible while taking this drug." c. "I will wear protective clothing when I am outdoors." d. "I will wear sunglasses even while I am indoors."
D
The nurse reviews information about a drug and notes the initials "United States Pharmacopeia (USP)" after the drug's official name. The nurse understands that this designation indicates the drug a. is a controlled substance. b. is approved by the FDA. c. is available in generic form. d. meets USP quality and safety standards.
D
The physician has ordered UGT1A1 gene testing for a patient with colon cancer. The nurse recognizes that which of the following drugs can result in severe diarrhea and neutropenia in persons with a specific UGT1A1 gene variant? a. Warfarin b. Carbamazepine c. Codeine d. Irinotecan
D
Which statement about the safety and efficacy of medications in children is accurate? a. Children cannot give consent, so clinical drug trials are not performed on children. b. Children can only be subjects in quasi-experimental clinical studies. c. Data from adult clinical drug trials should be extrapolated to children d. Federal law requires that drugs indicated for use in children be tested on children.
D
a 5 year old child with type 1 diabetes mellitus has had repeated hospitalizations for episodes of hyperglycemia. the parents tell the nurse that they can't keep track of everything that has to be done to care for their children. the nurse reviews medications, diet, & symptom management with the parents & draws up a daily checklist for the family to use. these activities are completed in which step of the nursing process? a. recognizing solutions (planning) b. analyze cues & prioritize hypothesis (analysis) c. generate solutions (planning) d. take action (nursing interventions)
D
all of the following would be considered subjective data, EXCEPT a. patient-reported health history b. patient-reported signs & symptoms of their illness c. financial barriers reported by the patient's caregiver
D
